TOP TIERMARKET NEWSWIRE
SEC Form 4 history

ETON PHARMACEUTICALS (ETON) insider trades

ETON PHARMACEUTICALS (ETON) insider trading activity (SEC Form 4). Over the trailing 90 days, ETON insiders filed 0 purchases totalling $0 and 5 sales totalling $16.5M — net SELLING of $16.5M. Most recent filing: Aug 28, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
5
$16.5M
Net (90d)
-$16.5M
net selling
Most recent
Aug 28, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Aug 28, 2026Maier Paul VDirS SaleOE—$59.07$3.0Mfiling
Aug 24, 2026Krempa DavidChief Business OfficerS SaleOE—$65.07$1.6Mfiling
Aug 20, 2026Brynjelsen SeanPres, CEOS Sale—$60.88$6.1Mfiling
Jul 16, 2026Opaleye Management Inc.10%S Sale—$37.54$1.1Mfiling
Jul 7, 2026Opaleye Management Inc.10%S Sale—$37.64$4.8Mfiling
Jun 17, 2026Adams Jennifer McKieDirS SaleOE—$32.48$1.6Mfiling
May 29, 2026Brynjelsen SeanPres, CEOS Sale—$31.88$3.8Mfiling
May 27, 2026Krempa DavidChief Business OfficerS SaleOE—$32.30$3.2Mfiling